Proficio Capital Partners LLC Makes New Investment in Solventum Co. (NYSE:SOLV)

Proficio Capital Partners LLC purchased a new position in Solventum Co. (NYSE:SOLV) during the 4th quarter, HoldingsChannel reports. The firm purchased 23,385 shares of the company’s stock, valued at approximately $1,545,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SOLV. Modus Advisors LLC acquired a new stake in Solventum during the 4th quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new stake in Solventum during the 4th quarter worth about $26,000. Crews Bank & Trust acquired a new stake in Solventum during the 4th quarter worth about $32,000. True Wealth Design LLC raised its holdings in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares during the period. Finally, Prospera Private Wealth LLC acquired a new stake in Solventum during the 3rd quarter worth about $35,000.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Bank of America lifted their target price on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. Morgan Stanley lifted their target price on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 5th. The Goldman Sachs Group lifted their target price on Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday, March 3rd. Wells Fargo & Company lifted their target price on Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Finally, Mizuho lifted their target price on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Solventum currently has a consensus rating of “Hold” and a consensus price target of $79.86.

Solventum Price Performance

Shares of SOLV stock opened at $74.98 on Friday. The stock’s fifty day moving average is $75.04 and its 200-day moving average is $71.44. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The stock has a market capitalization of $12.97 billion and a PE ratio of 27.27. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $85.92.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.